Secondary amyloidosis in an alkaptonuric aortic valve
Open Access
- 22 January 2014
- journal article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 172 (1), e121-e123
- https://doi.org/10.1016/j.ijcard.2013.12.117
Abstract
No abstract availableKeywords
Funding Information
- Telethon Italy (GGP10058)
- AimAKU (Associazione Italiana Malati di Alcaptonuria (ORPHA263402)
This publication has 10 references indexed in Scilit:
- Choice of Valve Prosthesis in a Rare Clinical Condition: Aortic Stenosis due to AlkaptonuriaNew Zealand Medical Journal, 2013
- Alkaptonuria-Associated Aortic StenosisJournal of Cardiac Surgery, 2013
- Aortic Valve Replacement for Aortic Stenosis Caused by AlkaptonuriaThe Annals of Thoracic Surgery, 2013
- Alkaptonuria is a novel human secondary amyloidogenic diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Biochemical and proteomic characterization of alkaptonuric chondrocytesJournal of Cellular Physiology, 2011
- Redox‐proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosisJournal of Inherited Metabolic Disease, 2011
- Proteomic and redox‐proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytesJournal of Cellular Biochemistry, 2010
- Development of an in vitro model to investigate joint ochronosis in alkaptonuriaRheumatology, 2010
- Evaluation of antioxiodant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell modelJournal of Cellular Physiology, 2010
- Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosisRheumatology, 2010